Abstract:Background: This review elucidates ongoing research, which show improved delivery of anticancer drugs alone and/ or enclosed in carriers collectively called nanomedicines to cross the BBB/ BTB to kill tumor cells and impact patient survival. We highlighted various advances in understanding the mechanism of BTB function that has an impact on anticancer therapeutics delivery. We discussed latest breakthroughs in developing pharmaceutical strategies, including nanomedicines and delivering them across BTB for brain tumor management and treatment. Methods: We performed an extensive literature search and highlighted important studies on the regulation of BTB permeability with respect to nanotech-based nanomedicines for targeted treatment of brain tumors. We have reviewed research articles that describe the development of specialized molecules and nanospheres, which carry payload of anticancer agents to brain tumor cells across the BBB/ BTB and avoid drug efflux systems. We highlighted research on the identification and development of targeted anti-cancer drug delivery to brain tumors. In addition, we discussed multimeric molecular therapeutics and nanomedicines that were encapsulated in nanospheres for treatment and monitoring of brain tumors. Results: In this context, we quoted our research on large conductance calcium-activated potassium channels (BKCa) and ATP-dependent potassium channels (KATP) as portals of enhanced antineoplastic drugs delivery. We showed that several innovative drug delivery agents such as liposomes, polymeric nanoparticles, dendrimers and many such tools can be utilized to improve anticancer drugs and nanomedicines across the BTB to reach brain tumor cells. Conclusion: This review might interest both academic and drug company scientists involved in drug delivery to brain tumors. We further seek to present evidence that BTB modulators can be clinically developed as combination drug or/ and as stand-alone anticancer drugs. Eventually, it is expected that unrelenting effort from the scientific community in developing novel drug delivery methods should increase the survival rate of brain tumor patients, which is dismally low presently.

Recent Advances in Brain Tumor-Targeted Nano-Drug Delivery Systems

Recent advances in drug delivery systems for targeting brain tumors

Novel Nano-Drug Delivery System for Brain Tumor Treatment

Brain tumor-targeted drug delivery strategies

Noninvasive Nanoparticle Strategies for Brain Tumor Targeting.

Targeting Brain Tumors with Nanomedicines: Overcoming Blood Brain Barrier Challenges

Strategies to Overcome/penetrate the BBB for Systemic Nanoparticle Delivery to the Brain/brain Tumor.

Research Advances in Brain-Targeted Nanoscale Drug Delivery System

Micro‐Nanocarriers Based Drug Delivery Technology for Blood‐Brain Barrier Crossing and Brain Tumor Targeting Therapy (small 45/2022)

“Smart” Nanocarriers: A New Paradigm for Tumor Targeting Drug Delivery Systems

Customizing delivery nano-vehicles for precise brain tumor therapy

Recent Advances in Drug Delivery Systems for Enhancing Drug Penetration into Tumors

Progress and Perspectives on Targeting Nanoparticles for Brain Drug Delivery

Emerging Nano-Carrier Strategies for Brain Tumor Drug Delivery and Considerations for Clinical Translation

Nanoparticle Strategies to Improve the Delivery of Anticancer Drugs across the Blood-Brain Barrier to Treat Brain Tumors.

Recent Progress of Drug Nanoformulations Targeting to Brain

Targeting brain tumors with innovative nanocarriers: bridging the gap through the blood-brain barrier

Brain-targeted nanoparticle drug delivery systems:research advances

Nanotechnology Driven Lipid and Metalloid Based Formulations Targeting Blood–Brain Barrier (3B) for Brain Tumor

Recent advances in biomimetic nanodelivery systems: New brain-targeting strategies

Recent Advances and Strategies in Tumor Vasculature Targeted Nano-Drug Delivery Systems